SFX by Ex Libris Inc.

Title:	Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
Source:	Science [0036-8075] Zuccato, C yr:2001

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Zuccato, C. "Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery." Pharmacological research 52.2 (2005): 133-9.
description	2.	Walker, Francis O. "Huntington's disease." Lancet, The 369.9557 (2007): 218-228.
description	3.	Rigamonti, D. "Wild-type huntingtin protects from apoptosis upstream of caspase-3." The journal of neuroscience 20.10 (2000): 3705-3713.
description	4.	Zuccato, C. "Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes." Nature genetics 35.1 (2003): 76-83.
description	5.	Kapfhammer, Raphael K. "Huntington's disease: Present treatments and future therapeutic modalities." International clinical psychopharmacology 19.2 (2004): 51-62.
description	6.	Kent, A. "Huntington's disease." Nursing standard 18.32 (2004): 45-51.
description	7.	Novak, Marianne J U J. "Huntington's disease." BMJ. British medical journal (Clinical research ed.) 340.30 (2010): 34-40.
description	8.	Halpin, M. "Diagnosis, psychiatry and neurology: The case of Huntington Disease." Social science & medicine 73.6 (2011): 858-865.
description	9.	Ross, Christopher A. "Huntington's disease: from molecular pathogenesis to clinical treatment." Lancet neurology 10.1 (2011): 83-98.
description	10.	Rubinsztein, David C C. "Huntington's disease: molecular basis of neurodegeneration." Expert reviews in molecular medicine 5.20 (2003): 1-21.
description	11.	Zuccato, C. "Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease." The journal of neuroscience 27.26 (2007): 6972-83.
description	12.	Serpe, Craig J. "Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice." Brain, behavior, and immunity (2005): 173-80.
description	13.	Chiara Zuccato; Elena Cattaneo;, C. "Brain-derived neurotrophic factor in neurodegenerative diseases." Nature Reviews Neurology 5.6 (2009): 311-322.
description	14.	Cattaneo, E. "Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease." Pharmacological research 52.2 (2005): 140-150.
description	15.	Gardian, G. "Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease." The Journal of biological chemistry 280.1 (2005): 556-563.
description	16.	Gauthier, Volkmar R. "Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules." Cell 118.1 (2004): 127-138.
description	17.	Romero, E. "Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm." Neuron 57.1 (2007): 27-40.
description	18.	Tam, M. "Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi." Nature cell biology 4.2 (2002): 95-105.
description	19.	Saudou, F. "Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions." Cell 95.1 (1998): 55-66.
description	20.	DUYAO, A L P. "INACTIVATION OF THE MOUSE HUNTINGTONS-DISEASE GENE HOMOLOG HDH." Science 269.5222 (1995): 407-410.